Clinical Trial Update: Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

View source ↗

Summary

The study suggests that angiogenic profiling and non-invasive imaging may help predict tumor progression in high-risk low-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• Low-grade Glioma

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Glioma | Status: COMPLETED